What Levamisole/Oxyclozanide Treats: Main Uses and Benefits

This combination is a veterinary product formulated to address internal parasites in livestock. It plays a role in managing conditions where internal challenges may cause noticeable physiological strain and systemic imbalance. This includes treatment for gastrointestinal and pulmonary nematode infections, as well as adult liver fluke infections.

Managing Symptoms of Discomfort and Strain

This formulation is used in areas where short-term symptomatic assistance is appropriate for conditions characterized by symptoms related to heightened physiological activity. It is relevant for managing symptoms that interfere with daily comfort, and may assist with maintaining functional stability in the affected animals. This is applied in addressing conditions presenting with systemic or localized discomfort.

Supporting Systemic Stability and Day-to-Day Comfort

This medicine is commonly used across conditions presenting with symptoms that interfere with daily functioning stemming from internal challenges. It offers supportive relief when symptoms interfere with routine activities and is applied in scenarios where additional management of discomfort is required. It helps improve day-to-day comfort during symptomatic periods.

---

Quick Fact: Assistance with Physiological Strain

This combination is commonly used across conditions presenting with symptoms that interfere with daily functioning, assisting with the easing of the overall symptom load during periods of heightened discomfort.

---

Regulatory References

1. UK Veterinary Medicines Directorate

Levamisole/Oxyclozanide is a compound anthelmintic whose official eligibility is defined strictly for specific livestock populations, according to governmental regulatory documents.

Eligibility Scope	Official Regulatory Status
Populations for whom use is allowed	Approved target species are Cattle, Calves, Sheep, and Goats.
Populations for whom use is contraindicated	Animals with impaired hepatic (liver) function or known hypersensitivity to the active substances.
Eligibility-related restrictions	Absolute prohibition on use for animals currently producing milk for human consumption.
Pregnancy and lactation eligibility	The product can be safely administered to pregnant or lactating animals.

Eligibility Classifications	Official Regulatory Constraint
Contraindicated Use	Must not be used within 14 days before or after treatment with organophosphorus compounds.
Conditional Caution	Care should be taken when treating heavily pregnant animals or those that are sick, weak, or under stress.
Age-related rules	No explicit minimum or maximum age threshold is documented; eligibility is determined by the animal's target species and bodyweight.

The regulatory profile strictly defines who can and cannot use this medicine by establishing the permitted species, specifying absolute contraindications based on organ function, and enforcing a time-bound prohibition regarding concurrent treatment with other compound types. The use is further structured by caution required for animals in certain physiological states.

The official regulatory documents for the Levamisole/Oxyclozanide combination define specific and critical interaction restrictions, primarily involving other parasiticides. The most stringent restriction is the Formal Prohibited Co-administration, where concurrent use with certain agents is contraindicated due to the documented risk of additive toxicity. Specifically, administration is prohibited alongside medicinal products containing organophosphorus compounds and diethylcarbamazine citrate.

This core restriction is formalized by a Timing-Based Interaction Rule: the product must not be administered within a 14-day period before or after treatment with these specific substances. The interaction profile is structured around the pharmacodynamic effects of the active ingredients, which is the basis for the officially documented risk of enhanced toxicity when combined with other agents that share similar pharmacological activities.

Beyond drug-drug interactions, the official label enforces a procedural administration restriction, stating that the oral suspension must not be physically mixed with other products prior to dosing. Furthermore, a Population-Specific Interaction Note is documented: the potential for overdose effects is officially noted as being enhanced in animals that have severe liver damage or are dehydrated at the time of administration.

Levamisole, an imidazothiazole, functions as a cholinergic agonist. It selectively binds to and activates nicotinic acetylcholine receptors (nAChR) on the muscle cells and ventral nerve cord of susceptible helminths. This binding induces sustained, spastic, depolarizing neuromuscular blockade. The resulting uncoordinated hypercontraction and subsequent flaccid paralysis of the worm lead to the paralysis and detachment of the parasites from host tissues.

Oxyclozanide, a salicylanilide, acts as an uncoupling agent of oxidative phosphorylation in the parasite's mitochondria. It disrupts the proton gradient across the inner mitochondrial membrane, preventing the synthesis of adenosine triphosphate (ATP). This inhibition of energy generation severely compromises the parasite's motility and survival and affects the cellular integrity of the parasite's tegument.

The combined molecular action exerts simultaneous disruption of neuromuscular transmission and helminthic energy metabolism.

How to Use Levamisole/Oxyclozanide: Official Administration Guidelines

Administration of Levamisole/Oxyclozanide is defined to ensure the correct dose is delivered via the approved method. The medicine is formulated as an oral suspension and must be administered exclusively by the oral drench route.

---

Official Dosing Principles and Preparation

Element	Official Instruction
Dosing Schedule	Must deliver mathbf7.5 mg Levamisole HCl and mathbf15 mg Oxyclozanide per mathbfkg body weight. The dose is calculated based on the individual animal’s accurate body weight.
Preparation	The container must be thoroughly shaken well before use to ensure the active ingredients are homogeneously suspended.
Administration Device	Delivery must utilize a suitable dosing gun system, the accuracy of which must be confirmed prior to use. Care is required to prevent pharyngeal damage.

---

Frequency and Context of Use

The standard protocol for this combination anthelmintic is a single administration for acute parasitic clearance. However, protocols define requirements for intermittent use in specific scenarios. Re-treatment may be necessary at mathbf10 – mathbf14 day intervals if animals are exposed to continuous re-infection, or a specific repeat dose mathbf72 hours later may be required for certain parasitic infections.

The product is generally safe for use in pregnant and lactating animals, though care should be exercised when treating heavily pregnant stock. The medicine must not be mixed with other products during administration.

Recent Research Overview

Clinical evidence regarding the Levamisole/Oxyclozanide combination primarily stems from its long-established use in veterinary medicine for the treatment of internal parasitic infections, such as those caused by gastrointestinal worms, lungworms, and liver flukes. Both Levamisole and Oxyclozanide have distinct mechanisms of action: Levamisole functions as a nicotinic acetylcholine receptor agonist, inducing neuromuscular paralysis in susceptible nematodes, while Oxyclozanide works by uncoupling oxidative phosphorylation in certain flukes, disrupting their energy metabolism. The combination is studied to provide a broader spectrum of action and to manage cases where parasite resistance to single-agent treatments may be present.

---

Efficacy and Pharmacokinetics

Research has examined the pharmacokinetics of the combination, particularly in ruminants (e.g., sheep and cattle), noting that factors like the species being treated can influence drug absorption and persistence in the bloodstream. Studies evaluating the combination’s influence on infection markers, such as fecal egg counts, have shown a significant reduction in counts for target parasites following administration. This evidence supports the combination’s use in programs designed to control ruminant internal parasites.

---

Human Use and Safety Context

It is important to note that Oxyclozanide is not generally used in human medicine. Levamisole, while historically used in human medicine (including for certain parasitic infections and briefly as an adjuvant for colon cancer), was withdrawn from the US market due to the risk of serious adverse effects, including agranulocytosis (a severe reduction in white blood cells). The safety data for the Levamisole/Oxyclozanide combination is thus largely contextualized within animal health and residue monitoring, with ongoing regulatory surveillance for potential risks associated with Levamisole in human use.

Common questions about Levamisole/Oxyclozanide (FAQ)

---

Q: What is the primary use of Hydroxychloroquine Sulfate?

Hydroxychloroquine Sulfate is indicated for the treatment or prevention of malaria and for the management of chronic inflammatory conditions such as rheumatoid arthritis and lupus erythematosus.

---

Q: How should I take Hydroxychloroquine Sulfate?

Dosing instructions are specific to the condition being treated and are determined by your prescribing doctor. The patient information leaflet contains detailed guidance.

It's important to use the medication exactly as prescribed and to discuss any decision to alter the dose or discontinue treatment with a healthcare provider.

---

Q: What are the common side effects of Hydroxychloroquine Sulfate?

Common side effects listed on the product label may include nausea, vomiting, diarrhea, stomach cramps, and headache.

Individuals who experience severe or persistent side effects should seek medical attention.

---

Q: Is it safe to take Hydroxychloroquine Sulfate during pregnancy?

The use of Hydroxychloroquine Sulfate during pregnancy requires a careful assessment of the potential benefits and risks.

Prescribing information advises discussing use with a healthcare provider. Patients who are pregnant or planning to become pregnant are advised to consult with a healthcare professional before starting or continuing treatment.

---

Q: Does Hydroxychloroquine Sulfate require specific monitoring?

Yes, long-term use is associated with a risk of retinal changes (retinal toxicity). The product information recommends regular ophthalmologic examinations, including visual field testing.

A healthcare provider will advise on the appropriate schedule for these check-ups.

Storage and Disposal Requirements for Levamisole/Oxyclozanide

Official regulatory documents define strict environmental and handling rules for Levamisole/Oxyclozanide to ensure stability and public safety.

---

Required Storage Conditions

Condition	Requirement
Temperature	Store below 30 C or 25 C, depending on the formulation.
Protection	Keep in a cool, dry, and well-ventilated place and protect from light.
Container	The container must be kept tightly closed.

The medicine must be stored out of the sight and reach of children.

Stability and Disposal

The product's stability is tied to its container. The post-opening shelf-life for some formulations is specified as either 6 months or 1 year.

Disposal must adhere strictly to local regulations. Unused product and waste must not be disposed of via wastewater or household waste and should be managed using take-back schemes to avoid release to the environment.